Sobre la capacidad discriminativa de diferentes autoanticuerpos en el diagnóstico del Lupus Eritematoso Sistémico

Echevarría Monteagudo, Damelia; Kokuina, Helena; Peña, Yahima; Santana Porbén, Sergio; Marrero Hernández, Delsy.
J. negat. no posit. results ; 5(11): 1333-1355, nov. 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-201153

Documentos relacionados

  1. [Pathogenesis of systemic lupus erythematosus (LES)].
  2. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
  3. Changes in the result of antinuclear antibody immunofluorescence assay on HEp-2 cells reflect disease activity status in systemic lupus erythematosus.
  4. Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.
  5. Glomerular targets for autoantibodies in lupus nephritis--an apoptotic origin.
  6. Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis.
  7. The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre.
  8. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
  9. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?].
  10. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.